AHSG tagSNPs associate with type 2 diabetes and dyslipidemia: studies of metabolic traits in 7,683 Danish whites

Objective: The gene encoding the α 2 Heremans-Schmid glycoprotein, AHSG , is a credible biological and positional candidate gene for type 2 diabetes and the metabolic syndrome, and previous attempts to relate AHSG variation with type 2 diabetes and obesity in Swedish and French Caucasians have been largely successful. We related seven frequent AHSG tagSNPs to a range of metabolic traits including type 2 diabetes, obesity, and dyslipidemia. Research Design And Methods: The polymorphisms were genotyped in 7,683 Danish whites using Taqman allelic discrimination or chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, providing a statistical power of more than 99% to replicate previous findings. Data were analysed in case-control and haplotype settings, and quantitative metabolic traits were examined for association. Moreover, epistatic effects between AHSG variants and IRS1 and ADRB2 polymorphisms were investigated. Results: The -469T>G (rs2077119) and IVS6+98C>T (rs2518136) polymorphisms were associated with type 2 diabetes ( P =0.007 and P =0.006, respectively, or P corr =0.04 and P corr =0.03 following correction for multiple hypothesis testing), and in a combined analysis of the present and a previous study -469T>G remained significant (OR 0.90 [0.84-0.97], P =0.007). Furthermore, two AHSG haplotypes were associated with dyslipidemia ( P =0.003, P corr =0.009). Thr248Met (rs4917) tended to associate with lower fasting and post-OGTT serum insulin release ( P =0.02, P corr =0.1 for fasting and P =0.04, P corr =0.2 for area under the insulin curve) and improved insulin sensitivity estimated by the homeostasis model assessment of insulin resistance (9.0 mmol/l ⋅ pmol/l mmol/l P =0.01, P corr =0.06). Indications of epistatic effects of AHSG variants with the IRS1 Gly971Arg polymorphism were observed for fasting serum triglyceride concentrations. Conclusions: Based upon present and previous findings common variation in AHSG may contribute to the inter-individual variation in metabolic traits.

[1]  Y. Ikeda,et al.  A promoter polymorphism of the α2-HS glycoprotein gene is associated with its transcriptional activity , 2008 .

[2]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[3]  T. Hansen,et al.  Studies of associations between the Arg389Gly polymorphism of the β1‐adrenergic receptor gene (ADRB1) and hypertension and obesity in 7677 Danish white subjects , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[4]  T. Hansen,et al.  Relationships between the functional PPARalpha Leu162Val polymorphism and obesity, type 2 diabetes, dyslipidaemia, and related quantitative traits in studies of 5799 middle-aged white people. , 2007, Molecular genetics and metabolism.

[5]  K. Burgdorf,et al.  Studies of the associations between functional β2-adrenergic receptor variants and obesity, hypertension and type 2 diabetes in 7,808 white subjects , 2007, Diabetologia.

[6]  G. Grunberger,et al.  Fetuin-null mice are protected against obesity and insulin resistance associated with aging. , 2006, Biochemical and biophysical research communications.

[7]  F. Schick,et al.  α2-Heremans-Schmid Glycoprotein/ Fetuin-A Is Associated With Insulin Resistance and Fat Accumulation in the Liver in Humans , 2006 .

[8]  H. Koyama,et al.  Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects. , 2006, Diabetes care.

[9]  C. Lavebratt,et al.  Polymorphism of the AHSG gene is associated with increased adipocyte β2-adrenoceptor function Published, JLR Papers in Press, July 16, 2005. DOI 10.1194/jlr.M500201-JLR200 , 2005, Journal of Lipid Research.

[10]  P. Froguel,et al.  A synonymous coding polymorphism in the alpha2-Heremans-schmid glycoprotein gene is associated with type 2 diabetes in French Caucasians. , 2005, Diabetes.

[11]  P. Arner,et al.  AHSG gene variant is associated with leanness among Swedish men , 2005, Human Genetics.

[12]  T. Hansen,et al.  Studies of the association of the GNB3 825C>T polymorphism with components of the metabolic syndrome in white Danes , 2005, Diabetologia.

[13]  W. Tian,et al.  Association of α2-HS glycoprotein (AHSG, fetuin-A) polymorphism with AHSG and phosphate serum levels , 2005, Human Genetics.

[14]  C. Lindgren,et al.  α2-Heremans–Schmid glycoprotein gene polymorphisms are associated with adipocyte insulin action , 2004, Diabetologia.

[15]  D. Nyholt A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. , 2004, American journal of human genetics.

[16]  Charlotte Glümer,et al.  A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99 (1) , 2003, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[17]  H. Cordell Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans. , 2002, Human molecular genetics.

[18]  G. Grunberger,et al.  Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. , 2002, Diabetes.

[19]  L. Kalabay,et al.  Correlation of maternal serum fetuin/alpha2-HS-glycoprotein concentration with maternal insulin resistance and anthropometric parameters of neonates in normal pregnancy and gestational diabetes. , 2002, European journal of endocrinology.

[20]  J. Weber,et al.  Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[21]  C. Dina,et al.  Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. , 2000, American journal of human genetics.

[22]  G. Grunberger,et al.  α2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor , 2000, Molecular and Cellular Endocrinology.

[23]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[24]  G. Bray,et al.  Differential expression of insulin receptor tyrosine kinase inhibitor (fetuin) gene in a model of diet-induced obesity. , 1998, Life sciences.

[25]  G. Grunberger,et al.  Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level. , 1993, Molecular endocrinology.

[26]  G. Pagès,et al.  Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity , 1989, Cell.